CUSIP: 75629V904
What is CUSIP 75629V904?
CUSIP 75629V904 identifies 75629V904 - RECURSION PHARMACEUTICALS IN - CALL in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 75629V904:
As of 31 Dec 2025, 0 institutional investors reported holding shares of RECURSION PHARMACEUTICALS IN - CALL.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $4.09 | 0 | |||
| 2025 Q3 | $4.88 | 0 | |||
| 2025 Q2 | $5.06 | 0 | |||
| 2025 Q1 | $5.29 | 0 | |||
| 2024 Q4 | $6.76 | 0 | |||
| 2024 Q3 | $6.59 | 0 | |||
| 2024 Q2 | $7.50 | 0 | |||
| 2024 Q1 | $9.97 | 0 | |||
| 2023 Q4 | $9.86 | 0 | |||
| 2023 Q3 | $7.65 | 0 | |||
| 2023 Q2 | $7.47 | 0 | |||
| 2023 Q1 | $6.67 | 0 | |||
| 2022 Q4 | $7.19 | 0 | |||
| 2022 Q3 | $10.56 | 0 | |||
| 2022 Q2 | $8.00 | 0 | |||
| 2022 Q1 | $7.14 | 0 | |||
| 2021 Q4 | $17.11 | 0 | |||
| 2021 Q3 | $30.00 | 0 |